BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. DNMT1, glucose metabolic process, Influenza, Lymphocyte, Pharmacogenetics, Aspirin)
Bookmark Forward

QuickView for EphB4 (gene)


Body Atlas

Most Correlated Tissues

  1. Ciliary ganglion
  2. Atrioventricular node
  3. Globus pallidus
  4. Macrophage of peripheral blood
  5. Transverse colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Non-immune hydrops fetalis
  2. Hydrops fetalis
  3. Non-fatal electric shock
  4. Antiphospholipid syndrome
  5. Anthrax
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Nizatidine
  2. proxyphylline
  3. Xylazine
  4. sporidesmin
  5. Carbenoxolone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ACAA1
  2. RARRES2
  3. LCP2
  4. EDA
  5. mir-7
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Biological Significance of EphB4 Expression in Cancer.
  2. SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related feta…
  3. Imbalanced EphB4/EphrinB2 Signaling Modulates Bone Resorption in Periodontitis Induced by Porphyromo…
  4. EphrinB2-EphB4 Signaling in Neurooncological Disease.
  5. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
  2. Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With A…
  3. Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelod…
  4. sEphB4-HSA in Treating Patients With Kaposi Sarcoma
  5. EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refr…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.